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ScienceDirectRyanodine receptor Ca2+ release channels (RyR) are the largest
intracellular ion channels known. The primary physiological role
of the RyR is to provide a ligand-regulated pathway for the
release of stored Ca2+ to regulate a diverse array of cellular
processes. This article highlights advances in RyR channel
structure, shedding new light on closed-to-open channel
transitions and on the mechanisms of channel gating in health
and disease. We also evaluate how recent studies on the self-
association of RyR in situ have revealed a potential relationship
between the dynamic organization of channels in clusters and
the termination of the regenerative feedback of Ca2+-induced
Ca2+ release. Lastly, we consider how this information might
impact on the development of new RyR-focused therapies.
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Introduction
Ryanodine receptors (RyR) are intracellular ion channels
that act as conduits for the regulated release of stored Ca2+
to affect diverse cellular processes. Initially identified as
‘feet’ structures in the sarcoplasmic reticulum (SR) of
native tissue [1,2], the molecular characterization of the
channel was facilitated by virtue of its interaction with the
insecticidal plant alkaloid ryanodine. A tetrameric arrange-
ment of 560 kDa subunits results in a channel of
2.2 MDa making RyR the largest ion channel structure
identified to date. Three mammalian isoforms (RyR1-3)
are expressed from different genes that exhibit a high level
of exonic organization and encode homologous proteins
that share common structural motifs/elements (Figure 1).
RyR1, 2 and 3 vary in their tissue distribution; RyR1 and
2 mediate the release of Ca2+ that binds to and activates
the contractile machinery during skeletal and cardiac
muscle contraction, respectively. RyR2 is also expressed
at low levels in mammalian brain. RyR3 is thought to play
a contributory role to modulating Ca2+ signalling inwww.sciencedirect.com smooth and non-muscle cell types and in excitable tissue
(e.g. brain). The three isoforms are also characterized by
different mechanisms of activation with RyR1 gated pri-
marily by mechanical interaction with the sarcolemmal
voltage-gated Ca2+ channel whereas RyR2 and RyR3 are
ligand-activated, mainly by cytosolic Ca2+. The efficacy
and precise mechanisms for ligand activation of RyR2 and
RyR3 are different.
This review focusses on how recent advances in the
understanding of RyR channel structure, gating and co-
operativity can be used to provide insight into key aspects
of the mechanisms of channel function. We will consider
how this new information can be reconciled with normal
RyR function and with channel dysfunction associated
with a wide range of skeletal and cardiac diseases (e.g.
arrhythmias provoked by chronic abnormalities in RyR2
channel phosphorylation or occurring as a consequence of
genetic mutations that sensitize the channel to activating
ligand).
New advances in RyR structure
The enormous size of the RyR channel, and the practical
limitations in generating material in sufficient quantities
required for crystallographic studies, mean that progress
in the determination of RyR structure has been compar-
atively slow. In the absence of crystallographic informa-
tion, RyR tetrameric structure has been investigated
using cryo-electron microscopy (cryo-EM), with early,
low-resolution, structures emerging since the late 1980s
[3,4]. Incremental technical improvements have
increased resolution so that structural information on
RyR1 and, to a lesser extent RyR2, is now approaching
atomic resolution. In 2015 three groups published high-
resolution structures of closed conformations of RyR1 [5–
7] and these studies have recently been comprehensively
and critically reviewed [8].
The physiological role of RyR2 in cardiac muscle is to
provide a ligand-regulated pathway for the release of
stored Ca2+ to initiate contraction, and disruption of
regulation results in disease and sudden death. As a
consequence, the processes underlying the conforma-
tional rearrangements between closed and open states
of RyR channels are of particular interest and in 2016 four
groups published high-resolution cryo-EM investigations
of the structural basis for gating in RyR1 [9,10,11]
and RyR2 [12].
There is broad agreement on the structural domains that
make up the RyR monomer (Figure 1) and the arrange-
ment of these monomers in the tetrameric channel.Current Opinion in Physiology 2018, 1:1–6
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Figure 1
Two dimensional representation of domain boundaries of the RyR1 monomer described in des Georges et al. [9]. The solid lines beneath the
layout correspond to the three structural elements depicted in the cartoon illustration of the RyR monomer which is based on the schema of des
Georges et al. [9]. Definitions of the abbreviated names of domains, and details of the residues included in each domain can be found in des
Georges et al. [9]. Equivalent domain boundaries and names used in the other investigations discussed in this article can be found in Bai et al.
[10], Wei et al. [11] and Peng et al. [12]. This cartoon structure is used in Figure 2 to provide an overview of the closed and open RyR
conformations observed in the studies discussed in this article.Higher resolution attained in des Georges et al. [9]
permitted the identification of distinct elements within
some of these domains. Different methods have been
used to capture open and closed RyR conformations and
these are summarized in Figure 2 and in the annotated
references. Information on the widest range of potential
conformations was obtained by des Georges et al. [9]
and we will use this study as a framework within which to
discuss the observations of all four investigations. des
Georges et al. identify three major structural regions of
the RyR1 monomer: the shell, the activation core and the
pore (Figure 1). In the absence of activating ligands des
Georges et al. [9] report a number of distinct conforma-
tions in which the pore is closed but the position of the
shell varies, moving up and down relative to the plane of
the SR membrane (Figure 2). Bai et al. [10] report
equivalent movements of the cytoplasmic shell in closed
conformations of RyR1, describing this as a ‘breathing
motion’.
For RyR1 activated by either Ca2+ alone or a combination
of caffeine and ATP, des Georges et al. [9] report
conformations in which the pore remains closed but the
structure of the activation core is altered, and describe
these conformations as ‘primed’ for activation. In 50% of
RyR1 structures exposed to a combination of Ca2+, caf-
feine and ATP the pore was open. In this conformation the
cytosolic shell and activation module lean away from the
central axis of the tetramer, opening the pore as the result
of bending and bowing of the pore-lining S6 helices.
Bai et al. [10] used a combination of Ca2+ and PCB95 to
obtain an open conformation of RyR1. Comparison with a
closed conformation demonstrated that transitionCurrent Opinion in Physiology 2018, 1:1–6 between the states involved structural rearrangement
of the channel’s central domain (broadly equivalent to
the activation core in des Georges et al. [9]), triggering
pore opening as the result of bending of S6.
Wei et al. [11] activated channels with Ca2+ followed by
incubation with ruthenium red, arguing that under these
conditions RyR1 would be stabilized in an open, blocked,
conformation. When compared with a closed RyR1 struc-
ture [6] the authors describe a ‘breathing motion’ of the
cytosolic shell in the transition, together with an upward
movement of the central domain that results in an out-
ward movement of S6 helices.
Closed and open conformations of the RyR2 channel
were reported by Peng et al. [12] respectively in the
absence of activating ligands and in the presence of Ca2+
and PCB95. Comparison of the resulting structures
revealed changes in the cytoplasmic shell and the central
domain similar to those observed in RyR1 by des Georges
et al. [9] and Bai et al. [10]. In RyR2 turning of the
central domain causes an outward motion of the cytosolic
ends of S6 helices to open the pore.
All closed conformations observed in these studies have a
physical barrier to cation translocation created by the close
apposition of hydrophobic residues of the pore-lining S6
helices. In both RyR1 [9,10,11] and RyR2 [12],
equivalent isoleucine residues form this cytosolic gate.
The deformation of S6 helices in the open conformation
widens the pore and removes the barrier to cation flow.
The open conformations reported in these studies are
ligand-activated. Both des Georges et al. [9] and Weiwww.sciencedirect.com
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Figure 2
Overview of RyR conformations. Each panel shows the source material and detergent used to extract RyR from the SR membrane, together with
the ligands used to manipulate channel open probability. Details of methods, concentrations, etc., can be found in the source articles.
Conformations of RyR are shown using the cartoon structure described in Figure 1. In each case two opposing monomers are used to depict the
conformation of the shell, activation core and pore of the channel. Equilibria between potential conformations in each sample are shown.
Conformations with a low probability of occurrence, and not observed, are shaded. See text for more detail. For des Georges et al. [9] and Wei
et al. [11] bound ligands are shown in the activation core (see source articles for details of residues involved). No potential binding sites were
identified in Bai et al. [10] and Peng et al. [12].et al. [11] identify a Ca2+ binding site, although not the
same site, within the activation/central domain of the
channel and des Georges et al. [9] additionally identify
binding sites for ATP and caffeine within the same region
of RyR1. Ligand-binding-dependent structural changes
are transmitted to both the cytoplasmic shell and the
pore to open the channel. The mechanism of activation
during E-C coupling is different for RyR1 and RyR2. The
trigger for RyR2 opening comes from an increase in
cytosolic Ca2+, while RyR1 opening is initiated by a
physical link to voltage-dependent structural rearrange-
ments of the sarcolemmal Cav1.1 channel. Bai et al. [10]
and Wei et al. [11] propose that physiological activation
of RyR1 involves an initial conformational alteration ofwww.sciencedirect.com the cytoplasmic shell that is transmitted through the
central region to the pore.
These studies have captured open conformations of RyR
by using conditions that maximize the likelihood of
channel opening. Functional studies of RyR gating have
established that a range of open, kinetically distinguish-
able, states exist with average durations measured in
milliseconds [13]. Given their very short duration, these
could never be captured in structural studies. However,
while other regions of the channel may show structural
variation, as these states have the same unitary conduc-
tance, it is probable that the structure of the pore in each
open state will be very similar. The high-affinityCurrent Opinion in Physiology 2018, 1:1–6
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conformation of reduced conductance and des Georges
et al. [9] obtained structural information for ryanodine-
modified RyR1. They conclude that ryanodine binds
within, and partially occludes, the open pore to reduce
conductance. This conclusion contrasts with functional
studies that used comparative molecular field analysis to
investigate the characteristics of ryanodine analogs that
determined modified conductance and indicated that
rather than directly obstructing the pore, ryanodine
reduces conductance by inducing or stabilizing confor-
mational alterations in the open pore [14].
Clustering of RyR channels: its role in
excitation-contraction coupling
It has become increasingly clear that RyR2 channel
distribution within the SR is critical in determining the
properties of cardiomyocyte Ca2+ handling. The Ca2+
induced Ca2+ release (CICR) mechanism inherent in
triggering the release of SR Ca2+ required for muscle
contraction is a positive feedback process, and yet cannot
be endlessly regenerative. This apparent paradox was
initially resolved using theoretical modelling [15] in
which the channels were positioned into small, function-
ally isolated groups or clusters, allowing ‘cluster bomb
activation’ to initiate and ‘stochastic attrition’ to termi-
nate the event. Subsequent observation of spatially iso-
lated Ca2+ sparks [16] provided the basis for local control
theory [17], which states that Ca2+ release does not spread
out of control because of the physical separation between
RyR2 clusters and because of the high Ca2+ concentration
required for activation. In recent years, the increasing
accessibility of super-resolution optical techniques has
revealed that RyR2s do not pack in regular
‘checkerboard’ arrays (as in skeletal muscle [18]) but
rather form an irregular network of channel clusters
[19,20]. Clusters were recently found to be irregularly
spaced and composed of different numbers of RyR2s
averaging 14–15 [20,21], much smaller than the 75–
100 previously estimated [22]. In silico modelling has
shown that the organization and size of clusters is
expected to affect both the sensitivity of the channels
to activation [23] and the termination of release [19],
affecting spark fidelity (i.e. the probability that a sponta-
neous channel opening triggers a Ca2+ spark [24]) and
duration [25].
Channel clustering is considered to be the result of
allosteric coupling between channels, which is thought
to allow simultaneous opening and coordinated closure
(known as ‘coupled gating’) [26,27] and also to
keep channels closed at low Ca2+ and open at activating
Ca2+ concentrations [23]. Indeed, coupled RyR2 channels
differ in their gating, exhibiting longer open and closed
times compared to single channels [26–28]. Recent trans-
mission electron micrographs of RyR2 [29], show the
channels interacting in two configurations: ‘adjoining’Current Opinion in Physiology 2018, 1:1–6 (side-by-side) and ‘oblique’ (similar to the ‘checkerboard’
arrangement of RyR1, but with the channels at a 12 angle
to one another, rather than parallel). The oblique inter-
action is through SPRY1 and P1 domains, and because
this is an asymmetric interaction compared to that pro-
posed for RyR1, there is steric hindrance to forming a
continuous checkerboard, instead favouring a less ordered
‘branched’ array, fitting with that which has been
observed in cardiac tissue [20,21,22]. Packing in similar
adjoining and oblique formation has also been observed in
rat ventricular myocytes in images generated using dual
tilt tomography to produce en face views of channels in
the SR [30]. This study found these arrangements to be
labile, with the two different packing orientations being
influenced by physiological conditions with mainly obli-
que packing observed upon phosphorylation or at low
Mg2+ concentrations, with higher Mg2+ concentrations
resulting in more side-by-side or adjoining channel pack-
ing. Interestingly, the presence of Mg2+ has also been a
requirement for the observation of coupled gating in
bilayer experiments [28].
However, whether the exact arrangement of channel
packing has functional implications for Ca2+ release is
currently unclear and the phenomenon of ‘coupled
gating’ is controversial. This is mainly due to the lack
of direct experimental evidence; even in recordings that
appear to evidence simultaneous gating of channels
[26,27] these data cannot be conclusively reconciled with
the relative spatial arrangements and physical interactions
of the multiple channels in the bilayer.
Despite this, it has been suggested that decreased allo-
steric coupling due to changes in cluster organization
plays a role in cardiac disease [23] with variation in cluster
distribution being observed in a sheep model of atrial
fibrillation [20], and altered coupled gating of mutant
RyR2s proposed to cause delayed after-depolarisations in
the genetic arrhythmia syndrome CPVT (catecholamin-
ergic polymorphic ventricular tachycardia) [31]. It has
been suggested that smaller or less organized clusters
(i.e. ones with gaps in them) are likely to have lower levels
of allosteric regulation and so would be likely to fire more
readily, contributing more to diastolic release [32]. This is
in keeping with the concept of unclustered channels
responding differently to local Ca2+ concentration [23].
However, as these leaky, ‘rogue’ channels are not part of a
cluster this prevents the formation of a spark, meaning
that this Ca2+ leak goes undetected by cellular spark
imaging methods i.e. sub-spark or quarky Ca2+ release
[23]. CPVT-linked human RyR2 mutation has been
proposed to result in reduced co-operativity of channel
gating, and in silico modelling has identified this as a
possible substrate for arrhythmia [31,33]. Future studies
are anticipated to unveil the packing order (i.e. whether
channels are in a side-by-side/adjoining or chequerboard/
oblique lattice arrangement), the uniformity of packingwww.sciencedirect.com
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cluster shape on RyR2 function.
Implications for RyR-targeted drug design
An important question remains as to how these insights
into RyR channel structure and organization can be used
to inform mechanism-based approaches to drug design
to treat cardiac disease. The long-held view is that the
structural and functional complexities of ion channels
preclude rational drug design [34]. The pore-forming
region of RyR is the site of promiscuous interaction with
canonical chemical structures that contain hydrophobic
and ionizable nitrogen groups (i.e. most anti-arrhyth-
mics) and to date, the only ligand that exhibits specific-
ity for RyR is ryanodine, which is not clinically useful.
Given that conventional anti-arrhythmics may not rep-
resent ideal starting points for new RyR-targeted drug
design, it is important to note that the emergence of
flecainide [35], carvedilol [36] and dantrolene [37,38] as
drugs reported to modulate RyR channel function have
come from ‘reverse translation’ (i.e. these are drugs with
established clinical benefit in which their mechanism of
action has been back-fitted to a direct or indirect inhibi-
tory effect on the RyR channel) rather than having
emerged from feed-forward development using RyR
structural information. We should comment specifically
on the mechanism of action of flecainide, which was
initially reported to directly block RyR2 [35]. In subse-
quent investigations [39], we have shown that block is
unlikely to be its mechanism of action; rather it acts via
modulation of intracellular Na+ and Ca2+ as a conse-
quence of use dependent block of sarcolemmal Na+
channels.
There is also the possibility that some newer chemical
entities (e.g. S107 [40], DP2114–2149 [41]) may promote
the stabilization of defective disease-linked interactions
between RyRs (i.e. inter-tetrameric) which could influence
long-range conformational ordering across clusters.
In summary, we do not believe that the newly elucidated
features of RyR structure will facilitate a step-change in
developing RyR2-targeted pharmacologies and nor do
these studies eliminate the need for the detailed func-
tional assessments of RyR2 channel-drug interaction.
The advances in the field considered in this review should
mark the beginning of a new phase of investigations in
which new structural insights continue to inform an
integrated structure-function approach at the molecular,
cellular and organ levels and ultimately in vivo.
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